Minerva Neurosciences, Inc. Deferred Income Tax Liabilities, Net
Minerva Neurosciences, Inc. (NERV) had Deferred Income Tax Liabilities, Net of $1.80 million as of 2021-09-30, per its 10-Q filed 2021-11-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2022-03-01
- 2021-09-30: Deferred Income Tax Liabilities, Net $1.80M.
- 2021-06-30: Deferred Income Tax Liabilities, Net $1.80M.
- 2021-03-31: Deferred Income Tax Liabilities, Net $1.80M.
- 2020-12-31: Deferred Income Tax Liabilities, Net $1.80M.
| Period end | Deferred Income Tax Liabilities, Net |
|---|---|
| 2021-09-30 | $1.80M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $1.80M 10-Q · filed 2021-08-02 |
| 2021-03-31 | $1.80M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $1.80M 10-K · filed 2022-03-01 |
| 2020-09-30 | $1.80M 10-Q · filed 2020-11-02 |
| 2020-06-30 | $1.80M 10-Q · filed 2020-08-03 |
| 2020-03-31 | $1.80M 10-Q · filed 2020-05-04 |
| 2019-12-31 | $1.80M 10-K · filed 2021-03-08 |
| 2019-09-30 | $4.06M 10-Q · filed 2019-11-04 |
| 2019-06-30 | $4.06M 10-Q · filed 2019-08-05 |
| 2019-03-31 | $4.06M 10-Q · filed 2019-05-06 |
| 2018-12-31 | $4.06M 10-K · filed 2020-03-09 |
| 2018-09-30 | $4.06M 10-Q · filed 2018-11-05 |
| 2017-12-31 | $4.06M 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |